Int'l
SALE
Proviron – Ice Pharmaceuticals
$57.60
Availability: In StockSubstance: Mesterolone
Manufacturer: Ice Pharmaceuticals
Pack: 50 tabs (20mg/tab)
Quick Comparison
| Settings | Proviron - Ice Pharmaceuticals remove | Liothzone - T3 100mcg. remove | Cytomed 25mcg – Liothyronine Sodium – Deus Medical remove | Halozone - Halotestin 10mg. remove | Anavamed 10mg – Oxandrolone – Deus Medical remove | Letrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention remove | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Name | Proviron - Ice Pharmaceuticals remove | Liothzone - T3 100mcg. remove | Cytomed 25mcg – Liothyronine Sodium – Deus Medical remove | Halozone - Halotestin 10mg. remove | Anavamed 10mg – Oxandrolone – Deus Medical remove | Letrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention remove | ||||
| Image | 
Int'l | 
EU | 
EU | 
EU | 
EU | 
EU | ||||
| SKU | ice-pharma-026 | RF-AlphaZone-upline5234 | 101AAS-DM-0-118 | RF-AlphaZone-upline2674 | 101AAS-DM-0-113 | 101AAS-HB-0-139 | ||||
| Rating | ||||||||||
| Price | $57.60 | $113.99 | $39.00 | $125.99 | $50.00 | $75.00 | ||||
| Stock | Out of stock | Out of stock | Out of stock | |||||||
| Availability | Out of stock | Out of stock | Out of stock | |||||||
| Add to cart | ||||||||||
| Description | Substance: Mesterolone Manufacturer: Ice Pharmaceuticals Pack: 50 tabs (20mg/tab) | ACTIVE INGREDIENT: T3 100MCG TABLET COUNT: 50 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: PEPTIDES DOSAGE MEN: 50-100 MCG/DAY DOSAGE WOMEN: 50-100 MCG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO | Active Ingredient: T3 25mcg Tablet Count: 50 Counts Active Half-life: 9 Hours Classification: Peptides Dosage Men: 50-100 Mcg/day Dosage Women: 50-100 Mcg/day Acne: Rarely Water Retention: No Hbr: No Hepatology: Low Aromatization: No | Product Name: Halotestin 10mg Active Ingredient: Fluoxymesterone 10mg Active Life: 9 Hours Drug Class: Androgen; Anabolic Steroid Detection Time: 11 Months Common Doses: 10-20 mg/day Blood pressure: Perhaps Acne: Yes Water retention: No Aromatisation: No Liver toxicity: High Decrease HPTA function: None | Active Ingredient: Oxandrolone 10mg Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 50-100 Mg/day Dosage Women: 5-30 Mg/day Acne: Rarely Water Retention: No Hbr: No Hepatoxity: Low Aromatization: No | CTIVE INGREDIENT: Letrozole 2.5mg TABLET COUNT: 30 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 2.5-5 MG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO Ship From: Europe | ||||
| Content | Fluoxymesterone 10mg x 100 tablets Fluoxymesterone has established itself as a high-quality drug with a high androgenic index. Fluoxy mesteronegives a great increase in strength. Suitable for preparation for competitions, when an athlete needs strength without a large set of muscle mass. In this case, the musculature gets the necessary hardness. | Letrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature. | ||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| Additional information |
|
Reviews
There are no reviews yet.